Merck Beats Third-Quarter Expectations as Keytruda and Gardasil Outperform
Merck exceeded third-quarter expectations, with Keytruda and Gardasil performing better than expected.
Related stories
Vale Net Profit Falls 53% in Third Quarter; EBITDA Drops 24%
M impact | EARNINGS | Oct 29, 2026, 10:42 PM UTC
Alignment Healthcare Reports Results for Quarter Ended September 30
L impact | EARNINGS | Oct 29, 2026, 10:34 PM UTC
Amazon gana 113.587 millones de dólares en nueve meses, un 101 % más
M impact | EARNINGS | Oct 29, 2026, 10:34 PM UTC
Black Diamond Group reports 3Q FFO of C$0.63 per share
L impact | EARNINGS | Oct 29, 2026, 10:34 PM UTC
Black Diamond Group reports third-quarter EPS of C$0.16
M impact | EARNINGS | Oct 29, 2026, 10:34 PM UTC
Coca-Cola Femsa Reports Revenue Growth in Colombia
The headline reports revenue growth in Colombia in the third quarter and through September.
M impact | EARNINGS | Oct 29, 2026, 10:34 PM UTC